September 11, 2014 Marina Galperina

The scientific community continues to embrace tentatively hug psychedelic therapy, and with good cause. In a new Johns Hopkins University study published in the Journal of Psychopharmacology, “just two or three experiences” tripping on mushrooms helped a dozen volunteers struggling with a long-term smoking addiction quit. The success rate is twice that of “the gold standard medication”/Big Pharma cessation aids like Pfizer Inc.’s Chantix. […]

Read More…